tiprankstipranks
Gain Therapeutics, Inc. (GANX)
NASDAQ:GANX
US Market
Want to see GANX full AI Analyst Report?

Gain Therapeutics (GANX) Ownership - Who Owns Gain Therapeutics?

461 Followers

Gain Therapeutics (GANX) Ownership Overview

0.03%1.76%0.08%1.35%96.78%
0.03%
Insiders
0.08% Other Institutional Investors
1.35% ETFs
96.78% Public Companies and
Individual Investors
The ownership structure of Gain Therapeutics (GANX) stock is a mix of institutional, retail, and individual investors. Approximately 3.19% of the company’s stock is owned by Institutional Investors, 0.03% is owned by Insiders, and 96.78% is owned by Public Companies and Individual Investors.
The ownership structure of Gain Therapeutics (GANX) stock is a mix of institutional, retail, and individual investors. Approximately 1.84% of the company’s stock is owned by Institutional Investors, 0.03% is owned by Insiders, and 1.35% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
430,902Institution1.01%775,624
399,886Institution0.94%719,795
313,639Institution0.74%564,550
144,159Institution0.34%259,486
30,004Institution0.07%54,007
14,400Insider0.03%25,920
5,260Institution0.01%9,468
733Institution<0.01%1,319

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
399,886Institution0.94%719,795
313,639Institution0.74%564,550
30,004Institution0.07%54,007
5,260Institution0.01%9,468
733Institution<0.01%1,319

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
430,902Institution1.01%840,259
144,159Institution0.34%259,486

FAQ

Who Owns Gain Therapeutics, Inc. (GANX)?
According to the latest TipRanks data, approximately 0.08% of the company's stock is held by institutional investors, 0.03% is held by insiders, and 96.78% is held by retail investors.
    What percentage of Gain Therapeutics, Inc. (GANX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.08% of Gain Therapeutics, Inc. (GANX) stock is held by institutional investors.
      What percentage of Gain Therapeutics, Inc. (GANX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 96.78% of Gain Therapeutics, Inc. (GANX) stock is held by retail investors.
        Who owns the most shares of Gain Therapeutics, Inc. (GANX)?
        Vanguard owns the most shares of Gain Therapeutics, Inc. (GANX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.